Determining topical product bioequivalence with stimulated Raman scattering microscopy
Journal of Controlled Release · 2024-03 · 367 · 864-876
DOI: 10.1016/j.jconrel.2024.02.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-03. Verfasst von Fotis Iliopoulos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown 02129, MA, USA. Hauptthemen laut MEDLINE: Skin, Nonlinear Optical Microscopy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: FDA HHS, US FDA.
Abstract (Originalsprache)
Generic drugs are essential for affordable medicine and improving accessibility to treatments. Bioequivalence (BE) is typically demonstrated by assessing a generic product's pharmacokinetics (PK) relative to a reference-listed drug (RLD). Accurately estimating cutaneous PK (cPK) at or near the site of action can be challenging for locally acting topical products. Certain cPK approaches are available for assessing local bioavailability (BA) in the skin. Stimulated Raman scattering (SRS) microscopy has unique capabilities enabling continuous, high spatial and temporal resolution and quantitative imaging of drugs within the skin. In this paper, we developed an approach based on SRS and a polymer-based standard reference for the evaluation of topical product BA and BE in human skin ex vivo. BE assessment of tazarotene-containing formulations was achieved using cPK parameters obtained within different skin microstructures. The establishment of BE between the RLD and an approved generic product was successfully demonstrated. Interestingly, within the constraints of the current study design the results suggest similar BA between the tested gel formulation and the reference cream formulation, despite the differences in the formulation/dosage form. Another formulation containing polyethylene glycol as the vehicle was demonstrated to be not bioequivalent to the RLD. Compared to using the SRS approach without a standard reference, the developed approach enabled more consistent and reproducible results, which is crucial in BE assessment. The abundant information from the developed approach can help to systematically identify key areas of study design that will enable a better comparison of topical products and support an assessment of BE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown 02129, MA, USA.
- Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring 20993, MD, USA.
- Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring 20993, MD, USA.
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 149 13th Street, Charlestown 02129, MA, USA. Electronic address: evans.conor@mgh.harvard.edu.
Förderung
- FDA HHS
- US FDA
Zitieren
APA
Iliopoulos, F., Tu, D., Pence, I. J., Li, X., Ghosh, P., Luke, M. C., Raney, S. G., Rantou, E., & Evans, C. L. (2024). Determining topical product bioequivalence with stimulated Raman scattering microscopy. Journal of Controlled Release, 367, 864-876. https://doi.org/10.1016/j.jconrel.2024.02.010
Vancouver
Iliopoulos F, Tu D, Pence IJ, Li X, Ghosh P, Luke MC, et al. Determining topical product bioequivalence with stimulated Raman scattering microscopy. Journal of Controlled Release. 2024;367:864-876. doi:10.1016/j.jconrel.2024.02.010
BibTeX
@article{Iliopoulos2024,
author = {Iliopoulos, Fotis and Tu, Dandan and Pence, Isaac J and Li, Xiaolei and Ghosh, Priyanka and Luke, Markham C and Raney, Sam G and Rantou, Elena and Evans, Conor L},
title = {Determining topical product bioequivalence with stimulated Raman scattering microscopy},
journal = {Journal of Controlled Release},
year = {2024},
volume = {367},
pages = {864--876},
doi = {10.1016/j.jconrel.2024.02.010}
}
EUVIMED